Level up your trading with our powerful tools and real-time insights all in one place.
The current INM market cap is 3.11M. The company's latest EPS is USD -11.4967 and P/E is -0.41.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 2.31M | 902k | 1.24M | 1.17M | 1.28M |
| Operating Income | -517k | -2.63M | -1.53M | -2.06M | -2.27M |
| Net Income | -339k | -2.54M | -1.48M | -1.72M | -1.94M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 1.09M | 4.14M | 4.6M |
| Operating Income | -9.15M | -9.94M | -17.27M | -8.38M | -8.14M |
| Net Income | -8.94M | -10.2M | -18.6M | -7.95M | -7.68M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 14.11M | 10.92M | 15.26M | 13.36M | 11.82M |
| Total Liabilities | 2.02M | 1.34M | 2.48M | 2.25M | 2.62M |
| Total Equity | 12.09M | 9.58M | 12.77M | 11.11M | 9.21M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 7.8M | 9.78M | 12.79M | 14.11M | 11.82M |
| Total Liabilities | 1.93M | 2.41M | 3.71M | 2.02M | 2.62M |
| Total Equity | 5.88M | 7.38M | 9.08M | 12.09M | 9.21M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -7.28M | -2.17M | -4.02M | -5.96M | -6.99M |
| Investing | -662k | N/A | -9k | -9k | -9k |
| Financing | 10.68M | N/A | 4.65M | 4.65M | 4.65M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -7.38M | -9.79M | -15.58M | -7.28M | -6.99M |
| Investing | 3.79M | -2k | -673k | -662k | -9k |
| Financing | -31k | 10.86M | 15.07M | 10.68M | 4.65M |
| Market Cap | 3.11M |
| Price to Earnings Ratio | -0.41 |
| Price to Sales Ratio | 0.68 |
| Price to Cash Ratio | 0.47 |
| Price to Book Ratio | 0.34 |
| Dividend Yield | - |
| Shares Outstanding | 667.67k |
| Average Volume (1 week) | 55.54k |
| Average Volume (1 Month) | 620.72k |
| 52 Week Change | -41.87% |
| 52 Week High | 15.576 |
| 52 Week Low | 2.414 |
| Spread (Intraday) | 0.72 (15.16%) |
| Company Name | InMed Pharmaceuticals Inc |
| Address |
340 - 200 granville street vancouver, british columbia V6C 1S4 |
| Website | https://www.inmedpharma.com |
| Industry | security systems service (7382) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
